(Q44970580)
Statements
1 reference
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity (English)
1 reference
Chaim Yosefy
1 reference
Eliahu Magen
1 reference
Ada Kiselevich
1 reference
Rita Priluk
1 reference
Daniel London
1 reference
Lior Volchek
1 reference
Reuven J Viskoper
1 reference
1 August 2004
1 reference
1 reference
Identifiers
1 reference